Limited Satisfaction and Increased Risk with Intra-Articular Corticosteroid Injections in Patients Who Have Hip Osteoarthritis Needing Total Hip Arthroplasty.

IF 3.4 2区 医学 Q1 ORTHOPEDICS
Allan K Metz, Joshua P Rainey, Brenna E Blackburn, Adam J Taylor, Christopher L Peters
{"title":"Limited Satisfaction and Increased Risk with Intra-Articular Corticosteroid Injections in Patients Who Have Hip Osteoarthritis Needing Total Hip Arthroplasty.","authors":"Allan K Metz, Joshua P Rainey, Brenna E Blackburn, Adam J Taylor, Christopher L Peters","doi":"10.1016/j.arth.2025.03.037","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The value of intra-articular corticosteroid injections (CSI) in the treatment of hip osteoarthritis has come into question due to concerns regarding efficacy and complication profile. This study aimed to assess patient satisfaction after CSI for hip osteoarthritis and the association of CSI with potential complications following subsequent total hip arthroplasty (THA).</p><p><strong>Methods: </strong>A survey was sent to 510 patients who received at least one CSI at our institution before THA. Data collected included reduction in visual analog scale (VAS) pain scores, duration of relief, patient satisfaction, and if the patient would elect to receive another CSI. A retrospective review of 1,090 THA patients at our institution was performed to evaluate the association of CSI to potential complications following THA. Chi-square, Fisher Exact, and logistic regression were used for comparison between groups. A total of 104 patients who had injections in 129 hips responded (response rate 20.4%); There were 45.8% of patients who had one injection per hip, with a mean of 2.2 injections per hip (range, one to 10).</p><p><strong>Results: </strong>Patients reported a mean reduction in VAS pain scores of 5.2 (SD = 3.2), with the average relief lasting 6.2 weeks (SD = 8.4). Of note, 16.5% reported no satisfaction after CSI, and 44.4% stated they would not undergo CSI again. Of the 1,090 THA patients that were retrospectively reviewed, 247 patients (22.7%) received a CSI before THA; this was associated with an increased rate of septic revision (2.0 versus 0.5%, OR [odds ratio] = 4.98, P = 0.014). There were no significant differences in aseptic revision rates (P = 0.28).</p><p><strong>Conclusions: </strong>Almost half of the patients who received a CSI before THA would not do so again, with average pain relief lasting approximately six weeks. Given the increased risk of septic revision for those who underwent CSI before THA, this draws further concern regarding the value of CSI before THA.</p>","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arth.2025.03.037","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The value of intra-articular corticosteroid injections (CSI) in the treatment of hip osteoarthritis has come into question due to concerns regarding efficacy and complication profile. This study aimed to assess patient satisfaction after CSI for hip osteoarthritis and the association of CSI with potential complications following subsequent total hip arthroplasty (THA).

Methods: A survey was sent to 510 patients who received at least one CSI at our institution before THA. Data collected included reduction in visual analog scale (VAS) pain scores, duration of relief, patient satisfaction, and if the patient would elect to receive another CSI. A retrospective review of 1,090 THA patients at our institution was performed to evaluate the association of CSI to potential complications following THA. Chi-square, Fisher Exact, and logistic regression were used for comparison between groups. A total of 104 patients who had injections in 129 hips responded (response rate 20.4%); There were 45.8% of patients who had one injection per hip, with a mean of 2.2 injections per hip (range, one to 10).

Results: Patients reported a mean reduction in VAS pain scores of 5.2 (SD = 3.2), with the average relief lasting 6.2 weeks (SD = 8.4). Of note, 16.5% reported no satisfaction after CSI, and 44.4% stated they would not undergo CSI again. Of the 1,090 THA patients that were retrospectively reviewed, 247 patients (22.7%) received a CSI before THA; this was associated with an increased rate of septic revision (2.0 versus 0.5%, OR [odds ratio] = 4.98, P = 0.014). There were no significant differences in aseptic revision rates (P = 0.28).

Conclusions: Almost half of the patients who received a CSI before THA would not do so again, with average pain relief lasting approximately six weeks. Given the increased risk of septic revision for those who underwent CSI before THA, this draws further concern regarding the value of CSI before THA.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Arthroplasty
Journal of Arthroplasty 医学-整形外科
CiteScore
7.00
自引率
20.00%
发文量
734
审稿时长
48 days
期刊介绍: The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信